Tag: AMR
AMR Challenge 2024-25, in collaboration with GAMRIF, announces 9 winners
The C-CAMP national AMR Challenge that was launched in Aug, 2024 received about 200 applications from innovators and startups across India
DBT partners Oxford Nanopore to launch two Genomic Centres of Excellence...
Institutes under the Department of BioTechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation Genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies
In a first globally, Indian Medical Association launches “IMA AMR Smart...
This innovative program aims to combat the rising threat of Antimicrobial Resistance by implementing advanced Antimicrobial Stewardship & Infection Prevention & Control strategies in healthcare facilities across India
Facing the Silent Threat: How AMR Imperils Our Future
Antimicrobial resistance poses a silent yet formidable threat to global health, economic stability, and societal well-being, writes Dr Prabhu Vinayagam
CAHO & Orchid Pharma strategic partnership kicks off with a national...
Beyond the conference, Consortium of Accredited Healthcare Organizations (CAHO) and Orchid aim to strengthen hospital capacities to address AMR in tier 1 and tier 2 cities and hospitals, working with CAHO member hospitals
IMA launches Commonwealth Alliance of Medical Professionals on Antimicrobial Resistance
This initiative unites leaders to address the escalating threat of AMR, particularly in India, which is recognized as a hotspot for antibiotic-resistant infections
Academia based innovators of indigenous herbal knowledge awarded patents
Working towards this, the National Innovation Foundation (NIF), an autonomous institution of the Department of Science and Technology (DST) recognized 26 outstanding knowledge holders with herbal patent grants
C-CAMP partners ICARS to support innovative solutions to address challenge of...
These innovations will then be tested on-ground for uptake and scale up through public sector networks
Orchid Pharma launches Orchid AMS division to combat the rising threat...
This new business unit aims to lead antimicrobial stewardship in India with innovative solutions covering 3000 hospitals and healthcare institutions over the next 2-3 years
Orchid Pharma and Cipla to launch antibiotic Cefepime-Enmetazobactam in India
The partnership aims to address antimicrobial resistance through the rapid deployment of novel treatments for serious infections